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Abstract Mortality statistics represent important end-
points in epidemiological studies. The diagnostic validity
of cerebral stroke and ischemic heart disease recorded as
the underlying cause of death in Norwegian mortality
statistics was assessed by using mortality data of partici-
pants in the Bergen Clinical Blood Pressure Study in
Norway and autopsy records from the Gade Institute in
Bergen. In the 41 years of the study (1965–2005) 4,387
subjects had died and 1,140 (26%) had undergone a post
mortem examination; 548 (12%) died from cerebral stroke
and 1,120 (24%) from ischemic heart disease according to
the mortality statistics, compared to 113 (10%) strokes
and 323 (28%) coronary events registered in the autopsy
records. The sensitivity and positive predictive value of
fatal cerebral strokes in the mortality statistics were 0.75,
95% confidence interval (CI) [0.66, 0.83] and 0.86 [0.77,
0.92], respectively, whereas those of coronary deaths were
0.87 [0.84, 0.91] and 0.85 [0.81, 0.89] respectively.
Cohen’s Kappa coefficients were 0.78 [0.72, 0.84] for
stroke and 0.80 [0.76, 0.84] for coronary deaths. In
addition to female gender and increasing age at death,
cerebral stroke was a negative predictor of an autopsy
being carried out (odds ratio (OR) 0.69, 95% CI [0.54,
0.87]), whereas death from coronary heart disease was not
(OR 1.14, 95% CI [0.97, 1,33]), both adjusted for gender
and age at death. There was substantial agreement
between mortality statistics and autopsy findings for both
fatal strokes and coronary deaths. Selection for post
mortem examinations was associated with age, gender and
cause of death.
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Introduction
The specific cause of death reported in mortality statistics
is a common endpoint in epidemiological studies and it is
generally used as a surrogate marker of morbidity. Ische-
mic heart disease and cerebral stroke are the two leading
causes of death in the industrialized parts of world
according to mortality statistics [1 265/id]. Both the dis-
ability and mortality attributable to vascular disease in
ageing populations highlight the need to identify factors
related to aetiology and prevention.
Despite the decreasing autopsy rates, post mortem
examination is still regarded as the most accurate means of
determining the cause of death [2 299/id, 3 285/id].
Previous studies on the validity of cerebrovascular
mortality rates against autopsy findings have concluded,
contradictorily, both that the numbers are unacceptable
[4 288/id] and that the overall numbers are largely reliable
[5 239/id]. During the last two decades, as diagnostic
technology and procedures have continued to improve, only
a limited number of studies have been published validating
mortality statistics on stroke or ischemic heart disease
against autopsy findings [6 304/id, 7 276/id, 8 282/id].
These studies were based on cohorts selected for post-
mortem examinations, and thus not able to address external
validity. In Norway, the official department known as Sta-
tistics Norway compiles information on time and cause of
death for all deceased inhabitants. The mortality statistics
regarding stroke and ischemic heart disease in Norway have
not been validated against autopsy findings since 1977 [5
239/id].
The aims of this study were to compare the accuracy of
the diagnoses given in the mortality statistics between
stroke and ischemic heart disease against autopsy findings,
and to identify predictors of a general post mortem
examination being carried out.
Methods
Study population
A random, population-based sample of 6,811 subjects
aged 20–75 in 1964 was invited to the Bergen Clinical
Blood Pressure Survey (1965–1971). Information from
their medical history and from a standardized clinical
examination was recorded for each of the participants.
The study details have been extensively described else-
where [9 266/id, 10 154/id]. Registration of mortality
began on 1 January 1964 and ended on the date of death,
date of emigration or on 31 December 2005, whichever
occurred first.
Mortality statistics
Since 1964 all residents of Norway have been assigned a
unique 11-digit identification number which includes their
date of birth. Name, address and identification number are
registered by the Central Population Register of Statistics
Norway, which by law must be kept up-to-date regarding
deaths and emigration. When a registered Norwegian dies
inside Norwegian borders, a death certificate is issued by a
physician, and sent to Statistics Norway. A death registered
on the basis of a medical death certificate is matched with
the corresponding identification number in the Central
Population Register. The registered underlying cause of
death is the disease (or injury) that initiates the series of
events that eventually leads to death [11 305/id]. Notifi-
cation of time, place and cause of death were obtained from
Statistics Norway and linked to our data file on the basis of
the identification numbers, with permission granted by the
Data Inspectorate, the Norwegian Directorate of Health and
Social Services, and the Regional Committee for Ethics in
Medical Research. Statistics Norway used the 7th, 8th, 9th
and 10th revision of the International Classification of
Diseases (ICD) during the study period from 1964 to 2005
(Table 1). The causes of death were grouped into the 65
causes in the ‘‘European shortlist’’ (Eurocodes) which are
used in the European official mortality statistics [12 307/
id]. The analyses were based on mortality from ischemic
heart disease (Eurocode 34, ICD10 I20–I25) and cerebro-
vascular disease (Eurocode 36, ICD10 I60–69), having
been given as the underlying cause of death.
Autopsy records
The autopsy assessments of the causes of death in this
cohort have previously been published [13 290/id].
Necropsy findings were recorded by means of SNOMED
codes. The Norwegian SNOMED has been prepared by the
Norwegian Pathology Association Code and Nomenclature
Committee in cooperation with the Competence Center for IT
in the health and social sector, and is based on the Systema-
tized Nomenclature of Medicine [14 291/id]. The selection of
SNOMED codes which identifies autopsy-verified fatal
Table 1 ICD codes (and corresponding ICD versions) used in Nor-
way during the study period covered by the variables fatal stroke and
coronary death [22 292/id]
Year of death ICD-version
in use
Fatal stroke
(Eurocode 36)
Coronary death
(Eurocode 34)
1964–1968 6/7 330–334 420, 422
1969–1985/
1986–1995
8/9 430–438 410–414
1996–2005 10 I60–I69 I20–I25
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strokes and coronary deaths is given in Table 5 in the
‘‘Appendix’’.
Statistical analyses
The causes of death recorded in the mortality statistics and
at autopsy from the Gade Institute Department of Pathology
were compared and tabulated according to the following
categories:
True positive: a correct match with the diagnosis from
the mortality statistics and at autopsy.
Over-diagnosed (false positive): case diagnosed in the
mortality statistics but not at autopsy. Over-diagnosed (%)
is the proportion of false positives divided by all the
positives according to the mortality statistics (test).
Under-diagnosed (false negative): case diagnosed at
autopsy but not in the mortality statistics. Under-diagnosed
(%) is the proportion of false negative cases divided by all
the positives according to the autopsy records (truth).
Sensitivity of the diagnosis in mortality statistics was
calculated as the proportion of true positives divided by all
the positives according to autopsy records.
Positive predictive value (PPV) was calculated as the
number of true positives divided by all the positives
according to the mortality statistics.
Overall agreement between the mortality statistics and
the autopsy results was assessed by Cohen’s kappa and its
95% confidence interval [15 297/id]. Kappa can be inter-
preted as the proportion of agreement beyond chance, and
Cohen’s kappa is the most commonly used kappa-type
statistic in epidemiological studies [16 296/id]. We adopted
the Landis and Koch classification [17 295/id], classifying
kappa between 0.00 and 0.20 as poor agreement; 0.21–0.40
fair agreement; 0.41–0.60 moderate agreement; 0.61–0.80
substantial agreement, and 0.81–1.00 almost perfect
agreement. Cox proportional hazard regression was used to
test the influence of hypertension upon stroke mortality or
death from ischemic heart disease defined by mortality
statistics (Eurocode 36 or 34) and autopsy records,
respectively, in order to assess whether the results were
comparable. Binary logistic regression was used to explore
potential predictors of autopsy. Analyses were performed
using SPSS software, version 15.0.
Results
Study population
By the end of 41 years of the study, 4,387 persons (64% of
the cohort) had died and 1,140 of these (26%) were
examined by autopsy at the Gade Institute. The ratio of
autopsies to the number of deaths decreased from 40% in
the period 1964–1975 to 11% in the period 1995–2005.
The autopsy ratio for the upper quartile of age at death (i.e.
84–103 years) fell from 25 to 4%. In participants dying
from stroke (according to mortality statistics), the autopsy
ratio decreased from 41 to 4%, whereas in those dying from
coronary heart disease it decreased from 38 to 14%.
Of the 1,140 subjects examined by autopsy at the Gade
Institute in Bergen only 742 (65%) of the autopsy-reports
were forwarded and/or recorded in the mortality statistics
(Fig. 1).
Of the specific causes of death recorded in mortality
statistics, 3,389 (77%) were not based on autopsy findings.
The 256 cases of death recorded at Statistics Norway as
having been examined by autopsy, but with no autopsy
record at the Gade Institute, were evenly distributed over
the entire period of the study (‘‘Appendix’’ Fig. 2). Until
1996 Statistics Norway recorded that the registered cause
of death was based on an autopsy if the physician issuing
the Death Certificate had indicated that an autopsy had
been planned, but in many of these instances a post mortem
examination never took place. The 398 individuals with
autopsy records available at the Gade Institute, but with
cause of death ‘‘not based on autopsy’’ in the mortality
statistics died mainly in the period before 1987 when
physicians ordering the post mortem examination were still
responsible for forwarding the results of the autopsy to
Statistics Norway. From 1987 the pathology departments
were responsible for forwarding the autopsy reports and
from 1996 Statistics Norway implemented systematic
procedures to adjust the registered cause of death according
to the findings of the autopsy (‘‘Appendix’’ Fig. 3).
Validity of the diagnosis of fatal strokes in Norwegian
mortality statistics
The validity of the diagnosis of fatal stroke in the mortality
statistics was assessed by comparing the mortality statistics
for which diagnosis had been based on autopsy results with
those for which it had not (Table 2). The prevalence of
fatal strokes in the mortality statistics was the same in the
two groups (34/398 = 8.5 vs. 64/742 = 8.6%).
Ofthe28under-diagnosed(falsenegative)fatalstrokesinthe
mortalitystatistics,theregisteredcausesofdeathwerediseases
of the circulatory system (Eurocode 33) in12 cases (including
ischemic heart disease (Eurocode 34) in 9 cases), pneumonia
(Eurocode39)in5cases,malignantneoplasm(Eurocode07)in4
casesandotherEurocodesin7cases.
Of the 13 over-diagnosed (false positive) fatal strokes
reported in the mortality statistics, the autopsy had identi-
fied diseases of the circulatory system in 9 cases (including
ischemic heart disease in 5 cases), diseases of the lungs/
airways in 2 cases, malignant neoplasm in 1 case and 1
other case.
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For fatal strokes the kappa coefficient indicated ‘‘sub-
stantial’’ agreement irrespective of whether autopsy results
were available to inform the mortality statistics or not
(Table 2). The positive predictive value of fatal stroke in
mortality statistics was slightly improved when autopsy
results were available, but the change of sensitivity was
not statistically significant (based on the overlapping of
confidence intervals).
The kappa coefficients calculated for the 4 different
quartiles of the follow-up period (before 1978, 1978–1986,
1987–1995, 1996–2005) were 0.83, 0.77, 0.70, and 0.85
respectively, showing no trend of increasing diagnostic
validity over time.
As hypertension is the most established risk factor for
cerebral stroke, we tested whether hypertension had pre-
dicted fatal stroke according to the mortality statistics
differently from fatal stroke according to the autopsy
records. We used Cox proportional hazard regression,
adjusted for age at the baseline examination (when the
blood pressure was measured) and for gender. With fatal
stroke from mortality statistics as the outcome the hazard
ratio was 1.71, 95% CI [1.4, 2.08] and as the outcome from
autopsy records the hazard ratio was 1.70, 95% CI [1.07,
2.68].
Validity of the diagnosis of coronary deaths
in Norwegian mortality statistics
As for stroke, the recorded coronary deaths in the mortality
statistics were divided into subgroups according to whether
the diagnoses were based on autopsy results or not, and the
validity of the mortality statistics was assessed (Table 3).
Study cohort at 
baseline (N 6811)
Dead by the end of 
follow -up (N 4387)
Cause of death recorded at Statistics Norway 
reported to be based on autopsy (N 998)
Autopsy reports available at 
the Gade Institute (N 1140) 
742
398
256
Fig. 1 Mortality and autopsy
data for the 6,811 survey
participants
Table 2 Validity of fatal strokes (Eurocode 36) recorded in Norwegian mortality statistics for 1,140 post mortem examinations, according to
whether the autopsy results were available or not
Eurocode 36 Sensitivity
[95% CI]
Positive predictive value
[95% CI]
Over-diagnosed
[95% CI]
Under-diagnosed
[95% CI]
Kappa
[95% CI]
Autopsy reported available 60/83 = 0.72 60/64 = 0.94 4/64 = 0.06 23/83 = 0.28 0.80
[0.63, 0.82] [0.88, 1.00] [0.003, 0.12] [0.18, 0.37] [0.72,0.87]
Autopsy reported unavailable 25/30 = 0.83 25/34 = 0.74 9/34 = 0.29 5/30 = 0.17 0.76
[0.70, 0.97] [0.59, 0.88] [0.12, 0.41] [0.03, 0.30] [0.64,0.88]
Total 85/113 = 0.75 85/98 = 0.87 13/98 = 0.14 28/113 = 0.25 0.79
[0.67, 0.83] [0.80, 0.93] [0.07, 0.20] [0.17, 0.33] [0.73,0.85]
CI confidence interval
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The prevalence of coronary deaths in the mortality statis-
tics was 79/399 (20%) in the subgroup where autopsy
results had been reported as unavailable, whereas it was
253/742 (34%) in the subgroup where autopsy results had
been reported as available.
Of the 40 under-diagnosed (false negative) coronary
deaths in the mortality statistics, the registered causes of
death were diseases of the circulatory system (Eurocode
33) in 20 cases (of which stroke (Eurocode 36) in 5 cases),
respiratory diseases (Eurocode 37) in 7 cases, malignant
neoplasm (Eurocode 07) in 7 cases and others in 6 cases.
Of the 48 over-diagnosed (false positive) coronary death
reports in the mortality statistics, the autopsy reports con-
cluded on diseases of the circulatory system in 20 cases (of
which stroke in 9 cases), diseases of the lungs/airways in
11 cases and malignant neoplasm in 2 cases, and others in
15 cases.
For coronary deaths the kappa coefficient increased
from ‘‘substantial’’ to ‘‘almost perfect’’ agreement when
the autopsy results were available to the mortality statistics.
The sensitivity of ischemic heart disease in the mortality
statistics was slightly improved when the autopsy results
were available, but for the positive predictive value the
difference was not statistically significant (based on the
overlapping confidence intervals).
In the 4 quartiles of the study period the combined
kappa coefficients were 0.81, 0.79, 0.81, and 0.83,
respectively.
With coronary death (Eurocode 34) from the mortality
statistics as the outcome the Cox proportional hazard ratio
associated with hypertension was 1.58, 95% CI [1.38,
1.82]. With coronary death verified from the autopsy
record as the outcome the hazard ratio was 1.52 95% CI
[1.17, 1.99], both adjusted for age at baseline and gender.
Predictors of post mortem examination
and the association to fatal stroke
The selection of deaths for autopsy in a general population
is not random. We tested the following potential predictors
for effect upon the odds of undergoing post mortem
examination: age at death (quartiles), period of death
(before 1987 vs. 1987 or later), gender, and cause of death
(cerebral stroke or coronary disease). The independent
variables were explored in bivariate and multivariate
analyses. Bivariate logistic regression included only the
predictor of interest and the outcome (autopsy). Multivar-
iate logistic regression included gender, age at death and
period of death. Cause of death was compared to all other
deaths (Table 4).
As can be seen from Table 4, death from cerebral stroke
was a negative predictor of referral for autopsy, whereas
death from coronary heart disease was not, both adjusted
for gender, period of death and age at death. Female gender
was also a negative predictor of autopsy. There was no
statistically significant interaction between the categorical
variables included in these analyses.
Discussion
Our study indicates that the validity of fatal cerebral stroke
as well as that of coronary death in the Norwegian mor-
tality statistics for the city of Bergen seems to be satis-
factory. The kappa coefficients, sensitivity and positive
predictive values range between 0.71 and 0.92. Our find-
ings are largely supported by the limited number of pre-
vious studies in this area [7 276/id, 3 285/id, 6 304/id].
Forty years ago a Norwegian study based on autopsy
records [5 239/id] also concluded that the over-all figures
for stroke deaths are generally reliable in the mortality
statistics.
The kappa coefficient of both the diagnoses fatal stroke
and ischemic heart disease in the mortality statistics did not
change significantly during the study period or across the
different ICD versions in use (results not shown). This is
somewhat surprising, as we have experienced an increased
access to more advanced diagnostic procedures over the
last decades, improving the accuracy of both diagnoses in
general. The fatal strokes may be clinically more obvious
Table 3 Validity of coronary deaths (Eurocode 34) recorded in Norwegian mortality statistics for 1,140 post mortem examinations, according to
whether the autopsy results were available or not
Eurocode 34 Sensitivity
[95% CI]
Positive predictive value
[95% CI]
Over-diagnosed
[95% CI]
Under-diagnosed
[95% CI]
Kappa
[95% CI]
Autopsy reported available 219/237 = 0.92 219/253 = 0.87 34/253 = 0.13 18/237 = 0.08 0.84
[0.89, 0.96] [0.82, 0.91] [0.09, 0.18] [0.04, 0.11] [0.79,0.88]
Autopsy reported unavailable 65/87 = 0.75 65/79 = 0.82 14/79 = 0.17 23/87 = 0.25 0.73
[0.66, 0.84] [0.74, 0.91] [0.09, 0.26] [0.17, 0.36] [0.64,0.81]
Total 284/324 = 0.88 284/332 = 0.86 48/332 = 0.15 40/324 = 0.12 0.80
[0.84, 0.91] [0.82, 0.89] [0.11, 0.18] [0.09, 0.16] [0.76, 0.84]
CI confidence interval
Validity of mortality statistics for fatal strokes and coronary deaths 225
123
than the non-fatal strokes and the diagnostic accuracy of
these cases may thereby be less influenced by the
increasing access to advanced technology. While the dis-
agreement between autopsy results and clinical diagnoses
remains fairly stable [18 303/id], the number of post
mortem examinations decreases. This may well result in an
increase in diagnostic errors in the future.
We found limited differences in the accuracy of the
mortality statistics according to whether the diagnoses
were autopsy-based or not. The value of an autopsy is only
adequately exploited if the results are correctly incorpo-
rated into mortality statistics. In previous studies up to 40%
of autopsied cases were not properly reported in mortality
statistics [19 300/id, 20 301/id]. The results from 421
(36%) autopsies conducted at the Gade Institute were not
taken into account by Statistics Norway (Fig. 1). These
autopsy results, which were mostly from the period before
1987, may not have been forwarded by the physician
ordering the post mortem examination. Some of the 256
cases without autopsy records at the Gade Institute, but
which had been reported as having autopsy results in the
mortality statistics, may have died and undergone autopsy
outside the city of Bergen. The routines regarding reception
and implementation of these data at Statistics Norway may
thus be in need of improvement. The proportion of non-
recorded autopsy results has decreased during the study
period but there might still be a potential for improvement.
Finally, we found that fatal stroke, increasing age and
female gender are negative predictors of post mortem
examination, whereas coronary deaths are not, which
agrees with the findings of a Finnish study [8 282/id]. It has
previously been shown that the location where death takes
place also contributes to the demand for autopsy (hospital
deaths are examined much more often than nursing home
deaths and death in surgical wards more often than deaths
in medical wards). Furthermore, more uncertain clinical
diagnoses tend to be selected for autopsy and the pathol-
ogists tend to favor the more unusual diagnostic groups [13
290/id, 21 302/id]. Lack of interest in autopsy may also
reflect lack of clinical involvement or therapeutic frustra-
tion. Thus the selection for post mortem examination is not
random.
Limitations to this study are the limited sample size and
that the necropsy findings are collected from a closed
cohort, whereas the official mortality statistics record
information on deaths in the entire (open) population. Thus
incidence rates may not be comparable across the autopsy
group and mortality statistics in general. Participation in
the Bergen Clinical Blood Pressure Survey was not a
predictor of selection towards autopsy (results not shown),
so our findings are roughly applicable to an age-matched
selection of subjects recorded in mortality statistics
between 1965–2005. We found under-representation of the
elderly, of females and of fatal strokes among the autopsy-
investigated deaths. This means that younger males, who
were not assumed to be dead from stroke (atypical
strokes?) tended to be examined post mortem. This skew-
ness would rather deflate than exaggerate the correlation
between mortality statistics and autopsy findings. The false
positive and false negative rates in this cohort ranged from
5 to 29%. Approximately half of the mismatches remained
inside the circulatory system, whereas the others were more
or less randomly distributed over the entire spectrum of
diseases, which reduces the risk of systematic errors.
Table 4 Predictors of autopsy for 4,387 subjects who died during follow-up
Autopsy OR bivariate (95% CI) OR multivariate (95% CI)
Yes (n = 1,140) No (n = 3,247)
Gender
Male 688 (59) 1,416 (45) 1 1
Female 475 (41) 1,763 (55) 0.57 (0.50, 0.66) 0.73 (0.63, 0.84)
Age at death
\68 410 (35) 651 (20) 1 1
68–75 366 (32) 690 (21) 0.84 (0.71, 1.01) 0.91 (0.76, 1.09)
76–83 258 (22) 900 (28) 0.46 (0.38, 0.55) 0.56 (0.46, 0.68)
84? 129 (11) 983 (31) 0.21 (0.17, 0.26) 0.32 (0.25, 0.41)
Year of death
1964–1986 747 (64) 1,316 (41) 1 1
1987–2005 416 (36) 1,908 (59) 0.38 (0.33, 0.44) 0.55 (0.47, 0.63)
Fatal stroke 100 (9) 448 (14) 0.58 (0.46, 0.72) 0.66 (0.52, 0.84)
Coronary death 336 (29) 785 (24) 1.25 (1.07, 1.45) 1.09 (0.93, 1.27)
OR Odds ratio, CI confidence interval, n number of cases
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Epidemiological research using endpoints defined as
fatal stroke or ischemic heart disease from mortality sta-
tistics is unlikely to be markedly biased and that the validity
regarding the fatal strokes is acceptable for this age-range.
Our findings may also be applicable to international
mortality statistics based on similar sources of data.
Conclusion
We have shown substantial validity of fatal cerebral strokes
and coronary deaths in Norwegian mortality statistics,
though there is still some potential for improvement.
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Appendix
See Table 5; Figs. 2, 3.
Table 5 Topographical and morphological SNOMED codes repre-
senting the underlying (alternatively immediate) cause of death from
autopsy records regarding fatal strokes and coronary deaths
Localisation T-code
Heart including
pericardium
31000, 32000, 32600, 32910, 33010, 33030,
35000, 38000, 39000, 39900, 43000, 43100
Brain 45510, X1110, X1120, X2000, X2070, X7000
Morphological finding M-code
Infarct 54700, 54705, 54720, 54750, 54790, 52000,
52110, 52200, 35100, 35101, 35190,
35300, 36050
Haemorrhage 37000, 37001, 37003, 37004, 38000
(also 58000, 32400, 324401, 32431,
32470, 32471 (if T-code represents brain))
32400, 324401, 32431, 32470, 32471
SNOMED Systematic Nomenclature of Medicine (pathology-coding
system), T-code topographical code, M-code, morphological code
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Fig. 2 Autopsy-based causes of death recorded in mortality statis-
tics and the respective availability of autopsy data at the Gade
Institute. [‘‘light grey’’ (N = 256 cases) denotes autopsies recorded
in the mortality statistics, though autopsy data were not registered at
Gade.]
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Fig. 3 Causes of death recorded without autopsy in mortality
statistics and the respective availability of autopsy data at the Gade
Institute. [‘‘dark grey’’ (N = 398 cases) denotes autopsies at the
Gade Institute, which were not registered in the mortality
statistics.]
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